[Surgical treatment for primary aldosteronism]

Area of Science:

• Endocrinology
• Cardiovascular Medicine
• Nephrology

Background:

• Primary aldosteronism is the most frequent cause of secondary hypertension in middle-aged individuals.
• It carries higher morbidity and mortality risks than essential hypertension due to target organ damage (heart, brain, vessels, kidneys).
• Early diagnosis and management are crucial for mitigating long-term health consequences.

Purpose of the Study:

• To outline the diagnostic and treatment strategies for primary aldosteronism.
• To emphasize the importance of high clinical suspicion for this condition.
• To highlight the benefits of timely intervention in reducing cardiovascular risk.

Main Methods:

• Screening involves a three-phase approach: initial detection, confirmation of hyperaldosteronism, and lateralization assessment.
• Diagnostic methods include biochemical tests and imaging studies.
• Treatment decisions are based on the underlying cause and patient preference.

Main Results:

• Successful management, whether medical (mineralocorticoid receptor antagonists) or surgical (unilateral adrenalectomy), can significantly lower blood pressure.
• Effective blood pressure control through treatment reduces the risk of cardiovascular morbidity and mortality.
• Early detection and intervention are key to preventing progressive target organ damage.

Conclusions:

• Primary aldosteronism necessitates a high index of suspicion in hypertensive patients.
• A structured screening and diagnostic process is essential for accurate identification.
• Both medical and surgical treatments offer significant cardiovascular benefits when blood pressure is adequately controlled.